IL1B and COVID-19: IL-1β secretion is reduced when SARS-CoV-2 was preincubated and neutralized with COVID-19 patient’s serum before infection of ACE2-A549 cells (Figure 3E), thus revealing that NLRP3 inflammasome is activated after viral entry into permissive host cells.